Table II.
Groups | Escape latency (s) | Times across platform (time) | quadrant (s) |
---|---|---|---|
Control | 26.7±4.5 | 2.3±0.3 | 14.6±2.3 |
Sevoflurane | 33.5±4.9a | 1.6±0.3a | 10.4±2.1a |
Compound | 28.2±4.6b | 2.1±0.4b | 13.2±2.4b |
P<0.05, comparison between sevoflurane group and control group
P<0.05, comparison between compound group and sevoflurane group.